Aclaris Therapeutics
ACRS
#8130
Rank
C$0.27 B
Marketcap
$3.91
Share price
-1.81%
Change (1 day)
175.51%
Change (1 year)

EPS for Aclaris Therapeutics (ACRS)

EPS in 2023 (TTM): -$2.09

According to Aclaris Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.23. In 2022 the company made an earnings per share (EPS) of -$1.91 an increase over its 2021 EPS that were of -$2.34.

EPS history for Aclaris Therapeutics from 2015 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.099.42%
2022-$1.91-18.4%
2021-$2.3435.83%
2020-$1.72-69.31%
2019-$5.62-3.22%
2018-$5.8067.63%
2017-$3.466.64%
2016-$3.2566.73%
2015-$1.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.13 40.65%๐Ÿ‡บ๐Ÿ‡ธ USA